Tom Van Blarcom

Company: Kyverna Therapeutics

Job title: Senior Vice President, Head of Research

Seminars:

Developing Allogeneic Cell Therapies for B-Cell Driven Autoimmune Diseases 4:00 pm

Promising outlook for treating autoimmune disease patients with CAR-T cells Establishing benefit with autologous CAR-T cells Expanding to treat this broad patient population with allogeneic CAR-T cellsRead more

day: Conference Day One